Genomind offers the Genecept Assay, a pharmacogenetic test marketed primarily to psychiatrists and mental health providers. It tests a panel of genes to help guide psychiatric medication selection. If you're considering Genomind but wondering whether there are alternatives that might be a better fit for your situation, you have options. The pharmacogenetic science behind these tests is standardized, but the services differ meaningfully in cost, accessibility, medication coverage, and whether you need a new DNA sample.
Pharmacogenetic test results are not a diagnosis and should never be used to self-prescribe or change medications without medical guidance. Always discuss your results with your healthcare provider before making any changes to your treatment plan.
Like GeneSight, Genomind's Genecept Assay must be ordered by a healthcare provider and requires a new DNA sample (cheek swab). If you've already had your DNA tested through 23andMe, AncestryDNA, or a whole-genome sequencing service, you're essentially paying to re-sequence genes you've already had sequenced. Services like Gene2Rx can analyze the pharmacogenetic variants directly from your existing data.
Genomind's pricing depends on insurance coverage and can be difficult to predict upfront. Out-of-pocket costs for clinical PGx tests like Genomind and GeneSight often run into hundreds or even thousands of dollars. If you already own your genetic data, using a service that analyzes existing files is significantly less expensive.
Genomind's panel is designed around psychiatric and neurological medications. It includes some genes beyond standard pharmacokinetic enzymes, such as genes related to the serotonin transporter (SLC6A4), dopamine receptor (DRD2), and methylation (MTHFR). However, the clinical actionability of some of these additional markers is debated, and the test may not cover non-psychiatric medications like statins, blood thinners, or pain medications where pharmacogenetics is equally well-established.
All reputable pharmacogenetic tests analyze the same core drug-metabolizing enzyme genes (CYP2D6, CYP2C19, CYP2C9, etc.) using the same clinical guidelines from CPIC and the FDA. The difference isn't in the science but in the delivery: how many medications are covered, how results are presented, how much it costs, and how accessible the test is.
Whether you use Genomind, GeneSight, Gene2Rx, or another service, the pharmacogenetic genes that matter most for medication decisions are well-established. Here are the key ones any good PGx test should cover.
The most clinically important pharmacogenetic gene. Metabolizes antidepressants (paroxetine, venlafaxine, fluoxetine, amitriptyline), ADHD medications (atomoxetine), pain medications (codeine, tramadol), tamoxifen, and beta-blockers (metoprolol). About 5-10% of people are poor metabolizers who process these drugs too slowly, and 1-2% are ultrarapid metabolizers who clear them too quickly.
Metabolizes SSRIs (sertraline, escitalopram, citalopram), clopidogrel (Plavix), proton pump inhibitors (omeprazole), and certain antifungals. Particularly important for cardiac patients on clopidogrel, where poor metabolizer status can mean inadequate clot protection.
Metabolizes warfarin and NSAIDs. Critical for patients on blood thinners, where dosing errors can cause bleeding or clotting events.
Affects statin transport and muscle pain risk. About 15-20% of people carry variants that increase susceptibility to statin side effects, particularly with simvastatin and atorvastatin.
When comparing PGx services, focus on the genes that matter for your medications. If you're primarily taking psychiatric medications, CYP2D6 and CYP2C19 are the most important. If you also take cardiovascular drugs, pain medications, or statins, you'll want a service that covers CYP2C9, SLCO1B1, and VKORC1 as well. Genomind's additional neuropsychiatric markers (like SLC6A4 and MTHFR) may provide supplementary information, but the CPIC-guideline genes are where the strongest clinical evidence lies.
Pharmacogenetic testing is valuable any time you're starting a new medication with strong PGx evidence, if you've struggled to find the right psychiatric medication, or if you want a comprehensive genetic profile to inform all future prescribing. The best time to test is before you need the results, since your genetics don't change. A single test covers you for life.
Learn how genetics may affect your response to these related medications:
Gene2Rx uses genetic data you already have (23andMe, AncestryDNA, VCF files) to generate a pharmacogenetic report covering 100+ medications across psychiatry, pain management, cardiology, and other drug classes. Genomind requires a provider order and a new cheek swab, and focuses primarily on psychiatric and neurological medications. Gene2Rx is typically much more affordable since it works with your existing data.
Genomind's panel includes some neuropsychiatric markers (like SLC6A4, DRD2, ADRA2A, and MTHFR) that go beyond standard drug metabolism. However, the clinical actionability of these additional markers is less established than the core pharmacokinetic genes (CYP2D6, CYP2C19, etc.) that all reputable services cover. The strongest, most guideline-backed PGx results come from the drug-metabolizing enzyme genes.
MTHFR is included in some PGx panels (including Genomind's) because it relates to folate metabolism, which may affect mood. However, major clinical guidelines do not include MTHFR-based medication recommendations, and its actionability for prescribing decisions is limited compared to CYP2D6 or CYP2C19. It's supplementary information rather than a primary driver of medication choices.
If you've already taken a Genomind test, those results are valid and useful. Gene2Rx can complement them by covering additional medications outside psychiatry (statins, blood thinners, pain medications) using your existing 23andMe or AncestryDNA data. The two reports together would give you the broadest pharmacogenetic picture.
Find out how your DNA may influence your response to Sertraline and other medications with a Gene2Rx pharmacogenetics report.
Get Your Report Try Our Free Calculator